# Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea

> **NCT02144181** · NA · COMPLETED · sponsor: **Ulthera, Inc** · enrollment: 88 (actual)

## Conditions studied

- Erythematotelangiectatic Rosacea
- Rosacea

## Interventions

- **DEVICE:** Ulthera System Treatment

## Key facts

- **NCT ID:** NCT02144181
- **Lead sponsor:** Ulthera, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-12
- **Final completion:** 2016-10
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2018-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02144181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02144181, "Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02144181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*